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▼PCR products are often cloned into a plasmid vector prior
to sequencing to obtain high-quality templates and to take
advantage of universal sequencing primers. However, this
strategy is only useful for obtaining a short single-stranded
sequence from each end of an insert. To obtain the sequence
of an insert larger than several hundred base pairs, shotgun
or nested deletion strategies must also be employed. Here
we introduce a modified plasmid vector that is specifically
designed for rapid cloning of PCR (and other) products and
for constructing nested deletions for sequencing large in-
serts.
The parent plasmid vector pZErO
TM
-1 (Invitrogen) is an
excellent cloning vector because it produces no background
of non-recombinant colonies, it does not require expensive
X-Gal for color selection, and the linearized ends do not
require dephosphorylation (Invitrogen Corporation’s Zero
Background Cloning Kit, Version C Instruction Manual).
We redesigned half of the polylinker region of pZErOTM-1
to include a recognition site for the blunt-end-producing
8-cutter restriction enzyme, Srf I (Fig. 1). This enzyme will
rarely cut within a fragment to be cloned, allowing a blunt-
ended insert such as a PCR product to be ligated into the
vector in the presence of both T4 ligase and Srf I in a
1-h reaction (Stratagene pCR-ScriptTM SK(+) Cloning Kit
Instruction Manual). High cloning efficiency is assured by
a selection procedure following transformation in which
only cells containing a recombinant plasmid can grow. In
addition to a NotI site already present, we added a third
8-cutter site, AscI, on the opposite side of the Srf I site. We
also added a 5’ CG overhang producing a 6-cutter site for
ClaI, which our nested deletion strategy requires (Ref. 1).
We named this modified vector pZErO-Z.
The general strategy for constructing nested deletions
is as follows. The cloned DNA in pZErO-Z is amplified
with universal primers [M13 reverse and M13 (−40)]. This
DNA is partially digested with one or more 4-cutter re-
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striction enzymes producing 5’ CG overhangs. The par-
tial digestion products produced by the 4-cutter enzymes
are pooled and then digested to completion with the two
8-cutter enzymes, NotI and AscI. Following dephospho-
rylation and a clean-up step, this DNA is ligated into
two vectors prepared by cutting pZErO-Z with NotI and
ClaI or with AscI and ClaI. After transformation and plat-
ing, insert sizes are determined by colony PCR using uni-
versal primers. Two nested sets of overlapping fragments
from the two ligations are selected for sequencing both
strands.
Protocol
Blunt-ended cloning into pZErO-Z
1. Prior to cloning, the ends of a PCR product can be
made blunt by treating the DNA with a thermostable
polymerase, Pfu (Stratagene), for 30 min at 72◦C in the
presence of deoxynucleoside triphosphates.
2. Fifty nanograms of supercoiled pZErO-Z vector is incu-
bated at room temperature for 1 h with 1−2-fold molar
excess of the PCR product, 2.5 U Srf I (Stratagene), and
1−5 Weiss units T4 DNA ligase, in a 10 µl reaction
containing 25 mM Tris-HCl (pH 7.5), 10 mM MgCl2,
10 mM dithiothreitol (DTT), 20 µg/ml bovine serum
albumin (BSA), and 1 mM ATP (added separately). The
ligation can be terminated by incubating the reaction
for 10 min at 65◦C.
3. One to twomicrolitres of the ligationmixture is used to
transform competent cells [we routinely use XL1-Blue
(Stratagene)]. Cells are spread on low salt Luria Broth
(LB) plates (5g/l NaCl) containing 100 mM IPTG and
50 µg/ml ZeocinTM antibiotic (Invitrogen). In our
hands, greater than 95% of colonies contain inserts,
as evidenced by colony PCR.
4. The insert is directly amplified from the colony by
adding plasmid-containing cells directly to a PCR re-
action. The PCR reaction contains 50 ng each of M13
reverse andM13 (−40) primers, 200mMdNTP, 1.5mM
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FIGURE 1. Multiple cloning site region of plasmid vector pZErO-Z. The sequence of the modified region replaces the sequence between PstI and ApaI,
introducing new restriction sites. The modified region contains the 8-cutter Srf I for rapid PCR cloning, as well as the standard blunt-end cloning site,
EcoRV. NotI and AscI are 8-cutter sites flanking the Srf I and EcoRV sites. They are designed for generating nested deletions of a cloned insert (see text for
details).
MgCl2, 50 mM KCl, 10 mM Tris (pH 8.3) and 1 U Taq
DNA polymerase (Boehringer Mannheim) per 50 µl re-
action. Cells are added either by direct transfer from a
colony using a 200 µl pipette tip (taking care not to
add too many cells and avoiding touching the agar),
or by adding 1−2 µl of cells grown for 2 h in a 1.5 ml
microcentrifuge tube containing 100 µl LB broth with
50 µg/ml ZeocinTM antibiotic (Invitrogen). The amplifi-
cation proceeds for 30 rounds following 5-min incuba-
tion at 95◦C to release plasmids from the cells. The am-
plification conditions are: 94◦C, 30 s; 55◦C, 30 s; 72◦C,
1−2 min. This is followed by a 5-min incubation at
72◦C. The PCR product is visualized by running 5 µl of
the sample on a 1% agarose gel.
Vector preparation for nested deletion
1. NotI/ClaI digestion: 1 µg of pZErO-Z plasmid vector
is double digested with NotI and ClaI in NEB buffer 3
(New England Bio-labs) with BSA for 30 min at 37◦C in
a total volume of 50 µl.
2. AscI/ClaI digestion: 1 µg of pZErO-Z plasmid vector is
double digested with AscI and ClaI in NEB buffer 4 with
BSA for 30 min at 37◦C in a total volume of 50 µl.
3. The reaction is heat inactivated for 20 min at 65◦C.
One microlitre of the digested vector is directly used
for ligation without purification.
Insert DNA partial digestion, transformation and insert screening
1. The insert DNA is amplified by colony PCR, as described
above, followed by purification using a QIAquick-spin
PCR purification column (Qiagen). Alternatively,
5−10 µg of plasmid DNA containing the insert can
be double digested with AscI and NotI in NEB buffer
3 at 37◦C for 1 h. The insert is then isolated by gel
purification. Approximately 2 µg of insert will be
required for subsequent steps. If the cloned DNA is
a PCR product, we recommend pooling four or more
independent clones prior to isolating the insert to
improve the likelihood of detecting PCR-induced
mutations in any one clone.
2. In separate reactions, insert DNA is partially digested
with 1U of HinP1 I or 1U of HpaII in a total volume
of 50 µl. Aliquots (16 µl) are taken from each reaction
after 10, 15 and 20 min and immediately incubated
at 65◦C for 20 min to inactivate the restriction en-
zyme. Half of each aliquot is visualized on a 1% agarose
gel to check for digestion. Optimal partial digestion
is achieved when approximately 25−50% of the inset
DNA remains undigested. The best partially digested
aliquot from each digestion is selected and the two
samples are pooled.
3. If the pooled DNA is from the colony PCR product, it is
double digested in the same buffer by adding 5 U each
of NotI and AscI and incubating the sample for 1 h at
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37◦C. At the same time 1 µl of shrimp alkaline phos-
phatase (USB)(1 U/µl) is added to dephosphorylate the
DNA ends. The reactions are terminated by incubating
the sample for 10 min at 65−70◦C. If the pooled DNA
is gel-purified insert DNA, only dephosphorylation is
necessary.
4. The sample is purified using a QIAquick-spin column,
and is eluted in 50 µl of water or 10% Tris/EDTA (TE)
buffer.
5. The purified insert DNA is ligated into the two pre-
pared vectors separately. The ligation is carried out at
16◦C for 2 h in a 10 µl reaction containing 20 ng of
prepared vector, 7.5 µl insert DNA, 1 Weiss U T4 DNA
ligase in a standard ligase buffer. Transformation is as
described above.
6. Two sets of nested partial deletions of the original
insert, one for each direction, are generated by the
two ligations. Nested sets of clones for DNA sequenc-
ing, representing a range of sizes and differing by
300−600 bp, can be identified by colony PCR using
the universal primers [M13 reverse andM13 (−40)] and
agarose gel electrophoresis. The PCR products are puri-
fied on a QIAquick-spin column and cycle sequenced
using a universal primer. For automated fluorescence
sequencing, ABI’s M13 (−21) can be used. For dye ter-
minator cycle sequencing, we prefer the primer P-5
(5’-CACTATAGGGCGAATTGGGC-3’), which is located
adjacent to the ClaI cloning site (Fig. 1). Having com-
plementary nested sets assures that both strands of the
insert are sequenced.
The PZErO-Z vector allows rapid cloning of PCR prod-
ucts and convenient DNA sequencing via the nested dele-
tion strategy. This approach has several advantages com-
pared with sequencing PCR products by primer walking.
These include the reliable production of high-quality DNA
templates from colony PCR amplification with universal
primers, the use of a single primer for all cycle sequencing
reactions, and an overall cost savings. The restriction en-
zymes used to generate the nested deletions, HinP1 I and
HpaII have only the bases C and G in their recognition se-
quences (GCGC and CCGG, respectively). For coding re-
gions, the two enzymes are generally adequate for produc-
ing complete nested sets for sequencing an entire insert.
For AT-rich regions, other restriction enzymes may be re-
quired, such as TaqI (TCGA) or MaeII (ACGT). However,
these enzymes can not be heat inactivated, and an addi-
tional purification step is required after partial digestion.
The procedure described above can be easily modified to
be used with blunt-end-producing 4-cutter enzymes. The
vector is available upon request by email.
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Products Used
Pfu DNA polymerase: Pfu DNA polymerase from
Stratagene
Srf I: Srf I from Stratagene
XL1- Blue: XL1- Blue from Stratagene
Zeocin antibiotic: Zeocin antibiotic from Invitro-
gen
Taq DNA Polymerase: Taq DNA Polymerase from
Boehringer Mannheim
Taq polymerase: Taq polymerase from Pharmacia
Taq polymerase: Taq polymerase from Bioline
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Bioline
Taq DNA polymerase: Taq DNA polymerase from
PE Applied Biosystems
Taq DNA Polymerase: Taq DNA Polymerase from
Boehringer Mannheim
Taq DNA polymerase: Taq DNA polymerase from
Life Technologies (Gibco BRL)
Taq DNA polymerase: Taq DNA polymerase from
Promega Corporation
Taq DNA polymerase: Taq DNA polymerase from
Stratagene
Taq DNA polymerase: Taq DNA polymerase from
Takara Shuzo
Taq DNA polymerase: Taq DNA polymerase from
Amersham Pharmacia Biotech
Zeocin antibiotic: Zeocin antibiotic from Invitro-
gen
NEB buffer 3: NEB buffer 3 from New England
BioLabs
QIAquick-spin PCR purification kit: QIAquick-
spin PCR purification kit from QIAGEN GmbH
QIAquick: QIAquick from QIAGEN GmbH
Alkaline Phosphatase: Alkaline Phosphatase
from Boehringer Mannheim
alkaline phosphatase: alkaline phosphatase from
Tropix Inc
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